Background: The relationship between bone health and adiposity and how it may be
| BACKGROUND
Type 1 diabetes mellitus (T1DM) is a chronic metabolic disorder that is often associated with an alteration in the quantity and distribution of adipose tissue. 1 In addition, people of all ages with T1DM are at a higher risk of fractures. [2] [3] [4] Although the underlying pathophysiology of diabetic osteopathy is complex and multifactorial, 5 there is a growing body of evidence that suggests that the interplay between fat and bone may generally plays an important role in conferring skeletal fragility. 6 Previous studies have reported an inverse association of bone marrow adiposity (BMA) with bone mineral density (BMD) in elderly people with osteoporosis and other metabolic conditions. 7, 8 Several clinical and experimental studies indicate that adipose tissue itself is not functionally uniform, and different adipose depots have distinctive characteristics including adipocytokine production 9 with visceral adipose tissue (VAT) playing an important role in the maintenance of bone health. 10, 11 Thorough, in vivo assessment of adiposity at multiple sites, including abdominal, total body and bone marrow, requires several methods of imaging and hitherto this has rarely been performed in humans. 11 There is an increasing realization that a comprehensive assessment of bone requires an assessment of bone microarchitecture as well as bone densitometry. 13 Metabolic conditions that may affect bone health, such as diabetes, are also associated with marked alterations in body composition, adiposity and BMA. 12 Our objective was to utilize a wide range of imaging tools to evaluate adiposity at several sites and assess its relationship to quantifiable, imaging-based markers of bone health in young women with and without T1DM. The underlying hypothesis was that the inverse association between adiposity and bone health exists irrespective of the body compartment and mode of assessment of bone health. By performing a multimodality assessment of bone health and adiposity, this study has also provided greater mechanistic insights into the link between bone and fat as well as the pathophysiology of diabetic osteopathy.
| METHODS

| Population
Between January and July 2014, nine healthy women and 17 women with T1DM between the ages of 17 and 34 years participated in a study of bone health and adiposity. Exclusion criteria included the presence of metallic implants and pacemakers, active or planned pregnancy or lactation, kidney disease, chronic use of drugs that are known to affect bone health and other chronic diseases that are known to be associated with an increased risk of fractures.
Information on personal health and lifestyle habits, including cigarette smoking, alcohol consumption, current medication, use of vitamins or calcium, age at menarche, use of oral contraceptives, hours of weight-bearing physical activity per week, history of fractures and a family history of early osteoporosis, was also collected. In the women with T1DM, information on age of diagnosis, disease duration, insulin therapy and the presence of microvascular complications was obtained from the case records. The study protocol was approved by the national research ethics service, and all participants provided written informed consent.
| Micro-MRI
MRI images of the proximal tibia with a resolution of 0.3 mm×0.3 mm×0.3 mm were acquired with a 3T MRI scanner (Siemens Verio, Erlangen, Germany) using a transmit/receive extremity coil which was suitable for knee imaging. The method used has been described previously 1, 13 but briefly, the images were acquired from the right proximal tibia using the epiphyseal growth plate as a reference, with the first slice positioned immediately distal and parallel to the growth plate and subsequent slices positioned distally along the tibia. The pulse sequence was a fully balanced steady-state free precession, and the acquisition was 3D. Standardized analysis was performed using the slice that was located at the insertion point of the patellar ligament. The images were coded and analysed blindly using software written in IDL (Research Systems Inc, Boulder, CO, USA)
to obtain measures for apparent bone volume to total volume ratio (appBV/TV), apparent trabecular number (appTbN), apparent trabecular thickness (appTbTh) and apparent trabecular separation (appTbSp).
Validation of the software was performed using a custom-made phantom as described previously.
13
| MR spectroscopy (MRS)
1H-MRS was performed using a 6-channel body array (anterior) and a 12-channel spine coil (posterior). Spectra were obtained from a 20 mm×20 mm×20 mm volume within the vertebral body of L3, using a method which has been described previously. 1, 13 A PRESS sequence with no water suppression was used with the following parameters:
TR=2000 ms, TE=30 ms, no. of averages=80, total scan time=4 minutes. Analysis was performed following fitting of the spectrum in the time domain using a nonlinear least-squares algorithm, AMARES 14 in the java-based magnetic resonance user interface (jMRUI) software package. 15 The area under the water peak and lipid peak were obtained and used to calculate the lipid-to-water ratio (LWR) and percentage fat fraction (%FF) as a measure of BMA 16 using the following equation:
| MRI of abdominal fat
Of the participants who had MRS scans, approval was also obtained to simultaneously assess abdominal fat using the 6-channel body array and the 12-channel spine coil. A T1-weighted turbo spinecho sequence was used to acquire five axial slices at the level of 
| Dual energy X-ray absorptiometry (DXA)
DXA of the total body (TB), lumbar spine at L2-L4 (LS) and femoral neck (FN) was performed by a Lunar Prodigy Scanner (GE Medical Systems, Waukesha, WI, USA). Outputs included bone area (cm ), and these data were used to calculate standard deviation scores (SDS) of TB, LS and FN-BMD and LS bone mineral apparent density. 17 DXA was also used to measure fat mass, and these data were used to calculate percentage FM and FM SDS to correct for age and sex.
| Statistical analysis
Data analysis was performed using Minitab 17, Minitab Inc, State College, PA. All data were described as medians and ranges; compari- 
| RESULTS
| Study participants
There were no significant demographic or anthropometric differences between the cases and controls ( Table 1 ). The median age of the 17 women with T1DM was 23.7 years (17.4, 34) , and the median age at diagnosis was 10.1 years (4.8, 14.8) with a median duration of diabetes of 13.6 years (6.8, 26.5). In the T1DM cohort, five (29%) reported a history of traumatic fractures and in three, the fractures had occurred before the diagnosis of diabetes. No fractures were reported in the healthy women group, and none of the participants were on routine vitamin supplementation. Of the 17 cases, nine (50%) had retinopathy of which eight had background retinopathy alone, two (7%) were being treated for hypertension, and three (18%) had microalbuminuria. One of the cases had stable Crohn's disease over the study period requiring only sulfasalazine therapy for 3 years prior to the baseline assessment. At the time of the study, the women with T1DM were on a median insulin dose of 2.5 IU/ kg/d (1.2, 3.7) and the median HbA1c was 75 mmol/mol (51 118).
| Measures of adiposity
Abdominal adiposity parameters measured by MRI and including CSA, SCAT, VAT and TAT, were higher in the T1DM cases compared to the healthy women (Table 2) (Table S1 ). Previous pregnancy (n)
Oral contraceptive use (n)
Physical activity (hr/wk)
| Measures of bone mineral status & microarchitecture
No significant difference in DXA or MRI-based parameters was evident between women with or without T1DM ( Table 2 ). In the whole cohort of participants, body weight showed a clear association to DXA-BMD but not to MRI-measured bone microarchitecture ( Figure   2 ). On the other hand, age showed a clear association to appTbN and appTbSp but not BMD over the age range studied (r, −.61, P=.001 and r, .45, P=.02, respectively) and the extent of this association was not influenced by the coexistence of DM (Figure 3) . On assessing the association between age and appTbN for the cases and controls separately, the association remained significant for the former (r, −.5, P=.04
and r, −.54, P=.09, respectively) ( Figure 3 ). Although the association between DXA-measured TB-BMD, FN-BMD and LS-BMD was strong as expected, the association of these DXA parameters with MRI-based microarchitectural parameters was weak and not significant (Table S2) . CSA, cross-sectional area of adipose tissue; SCAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; TAT, total adipose tissue; TB FM, total body fat mass; TB-BMC, total body bone mineral content; TB-BMD, total body bone mineral density; LS-BMC, lumbar spine bone mineral content; LS-BMD, lumbar spine bone mineral density; LS-BMAD, lumbar spine bone mineral apparent density; FN-BMC, femoral neck bone mineral content; FN-BMD, femoral neck bone mineral density; appBV/TV, apparent bone volume/total volume; appTbN, apparent trabecular number; appTbSp, apparent trabecular separation; appTbTh, apparent trabecular thickness; BMA, bone marrow adiposity; FF%, fat fraction.
analysis and an association between vertebral BMA and TB-BMD was still evident (P=.04).
| DISCUSSION
To our knowledge, this is the first study to characterize relationships between measures of adiposity with DXA and MRI-based measures of bone parameters in young women. The study was limited by its small size. However, by including a group of women with T1DM within our study cohort, we were also able to explore relationships over a wider range of adiposity.
As osteoblasts and adipocytes share the bone marrow-derived mesenchymal stem cells (MSC) as a common precursor, 18, 19 it is hypothesized that an increase in adipogenesis may impair bone integrity through reducing osteoblastogenesis. 19 The study clearly showed that VAT and BMA are negative predictors of BMD. The inverse relationship between DXA-based measures of bone parameters at multiple skeletal sites and BMA has been reported in a range of people across the age span as well as those with anorexia nervosa, on glucocorticoid therapy and other osteoporotic conditions. [20] [21] [22] Rodent models of acute T1DM are also associated with higher BMA, 23 and although stable T1DM may not be associated with raised BMA, 1 in people with diabetes, BMA may be inversely related
The relationship between vertebral bone marrow adiposity expressed as fat fraction (FF %) as assessed by MRS and abdominal adipose tissue as assessed by MRI. Cross-sectional area (A), subcutaneous adipose tissue (B), visceral adipose tissue (C) and total adipose tissue (D) in women with type 1 diabetes (filled circles, solid regression line) and in healthy women (open circles, broken regression line). The correlation (r) and its P-value (P) are for the combined group of women to BMD. 24 The current findings provide additional support for this inverse relationship and also confirm that this relationship is found in health and disease. Whilst it is plausible that these relationships may be altered in people with diabetes, the current study did not show that the relationship, itself is altered. It is possible, however, that this relationship may vary from one pathological condition to another 13 and this requires further exploration. Recent studies also suggest that unsaturated bone marrow lipids may be more strongly associated than overall BMA with fragility fractures in diabetes 8, 25 and there is a need to explore this further.
In the present study, we observed an inverse relationship between BMA and BMD in nonanatomically-matched regions such as the spine for BMA and femoral and total body for BMD, as well as in anatomically-matched region such as the spine. Therefore, it is reasonable to assume that both MSC differentiation at a local level and hormonal factors at a systemic level contribute to the observed inverse relationship between BMA and BMD. These observations will be further strengthened by an assessment of bone microarchitecture and BMA at other skeletal sites in the future. MRI with its ability to study microarchitecture as well as BMA promises to be a useful imaging Recent studies including the current study have 36 reported a deficit in bone microarchitecture, as assessed by MRI, in people with T1DM and especially those who have some evidence of a vasculopathy. 1, 36 In contrast, such a consistent abnormality in DXA-based bone parameters in T1DM is rarely described. CSA, cross-sectional area of adipose tissue; SCAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; TAT, total adipose tissue; TB FM, total body fat mass; TB-BMC, total body bone mineral content; TB-BMD, total body bone mineral density; LS-BMC, lumbar spine bone mineral content; LS-BMD, lumbar spine bone mineral density; LS-BMAD, lumbar spine bone mineral apparent density; FN-BMC, femoral neck bone mineral content; FN-BMD, femoral neck bone mineral density; appBV/TV, apparent bone volume/total volume; appTbN, apparent trabecular number; appTbSp, apparent trabecular separation; appTbTh, apparent trabecular thickness; BMA, bone marrow adiposity.
F I G U R E 4
The relationship between visceral adipose tissue as assessed by MRI and TB-BMD SDS in women with type 1 diabetes (filled circles, solid regression line) and in healthy women (open circles, broken regression line). The correlation (r) and its P-value (P) are for the combined group of women well as healthy women. A comprehensive assessment of bone health may require an approach that combines conventional assessment by DXA with an assessment of BMA and microarchitecture by MRI.
